HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q4 2019 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO)
Q4 2019 Earnings Conference Call
February 24, 2020 04:30 p.m. ET
Company Representatives
Helen Torley - President, Chief Executive Officer
Al Kildani - Vice President of Investor Relations and Corporate Communications
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Jason Butler - JMP Securities
Jim Birchenough - Wells Fargo
Jessica Fye - JP Morgan
Graig Suvannavejh - Goldman Sachs
Joe Catanzaro - Piper Sandler
Joel Beatty - Citi
Gena Wang - Barclays
Ben Shim - Canaccord
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Halozyme,